jpndJoint program’s BIOMARKAPD project (2012-2015) aimed to standardize collecting, measuring and interpreting Alzheimer’s disease and Parkinson’s disease¬†biomarker measurements across Europe. Together with colleagues around Europe¬†we have developed a health-economic decision model to evaluate the added value of biomarkers in clinical practice.

Results indicated an improvement of the prediction of any-type dementia as well as the potential cost-effectiveness (to-be published soon) of the lumbar puncture.

Leave a Reply

Your email address will not be published. Required fields are marked *